Smart bombs for lung cancer: new ADC drugs enter trial

NCT ID NCT06780098

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This phase 2 trial tests two antibody-drug conjugates (ADCs) — R-DXD and I-DXD — against standard chemotherapy in 144 people with advanced squamous non-small cell lung cancer that has worsened after initial treatment. ADCs are like guided missiles that deliver a cancer-killing drug directly to tumor cells. The study measures how many tumors shrink and how safe the treatments are.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Raludotatug deruxtecan and Ifinatamab deruxtecan (antibody-drug conjugates)
What this could lead to
If successful, these antibody-drug conjugates could offer a new treatment option for people with advanced squamous lung cancer that has stopped responding to standard therapies.
What could go wrong
This is a phase 2 trial with only 144 participants, so results are preliminary. The treatments may not work better than chemotherapy and could cause side effects like infusion reactions or organ damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ankara Bilkent Şehir Hastanesi. ( Site 0142)

    RECRUITING

    Ankara, 06800, Turkey (Türkiye)

  • Azienda Ospedaliera Universitaria Careggi ( Site 0173)

    RECRUITING

    Florence, 50134, Italy

  • Bacs-Kiskun Varmegyei Oktatokorhaz ( Site 0063)

    RECRUITING

    Kecskemét, Bács-Kiskun county, 6000, Hungary

  • Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 0141)

    RECRUITING

    Adana, 01250, Turkey (Türkiye)

  • Beijing Cancer Hospital ( Site 0301)

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Bradfordhill ( Site 0162)

    RECRUITING

    Santiago, Region M. de Santiago, 8420383, Chile

  • Centro de Estudios Clínicos SAGA ( Site 0161)

    RECRUITING

    Santiago, Region M. de Santiago, 7500653, Chile

  • Charite-Universitaetsmedizin Berlin ( Site 0191)

    RECRUITING

    Berlin, 13353, Germany

  • Chongqing University Cancer Hospital ( Site 0304)

    RECRUITING

    Chongqing, Chongqing Municipality, 400030, China

  • EVANGELISMOS S.A ( Site 0206)

    RECRUITING

    Athens, Attica, 106 76, Greece

  • Ege Universitesi Hastanesi ( Site 0143)

    RECRUITING

    Izmir, İzmir, 35100, Turkey (Türkiye)

  • European Interbalkan Medical Center-Oncology Department ( Site 0205)

    RECRUITING

    Thessaloniki, 570 01, Greece

  • FALP ( Site 0160)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)

    RECRUITING

    Milan, 20133, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0174)

    RECRUITING

    Roma, 00168, Italy

  • Fujian Provincial Cancer Hospital ( Site 0310)

    RECRUITING

    Fuzhou, Fujian, 350014, China

  • Guangxi Medical University Cancer Hospital ( Site 0303)

    RECRUITING

    Nanning, Guangxi, 530201, China

  • Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 0140)

    RECRUITING

    Ankara, 06230, Turkey (Türkiye)

  • Henan Cancer Hospital ( Site 0311)

    RECRUITING

    Zhengzhou, Henan, 450000, China

  • Hospital Clinic de Barcelona ( Site 0092)

    RECRUITING

    Barcelona, 08008, Spain

  • Hospital Universitario Quiron Madrid ( Site 0091)

    RECRUITING

    Madrid, 28223, Spain

  • Institut Català d'Oncologia - L'Hospitalet ( Site 0090)

    RECRUITING

    L'Hospitalet de Llobregat, Barcelona, 08908, Spain

  • Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0144)

    RECRUITING

    Istanbul, 34098, Turkey (Türkiye)

  • Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet ( Site 0061)

    RECRUITING

    Szolnok, Jász-Nagykun-Szolnok, 5000, Hungary

  • MedStar Franklin Square Medical Center ( Site 0033)

    RECRUITING

    Baltimore, Maryland, 21237, United States

  • Meir Medical Center ( Site 0071)

    RECRUITING

    Kfar Saba, 4428164, Israel

  • Nanjing Drum Tower Hospital JiangBei International Branch Hospital ( Site 0309)

    RECRUITING

    Nanjing, Jiangsu, 210031, China

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0151)

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • Ospedale San Raffaele. ( Site 0171)

    RECRUITING

    Milan, 20132, Italy

  • Petz Aladar Egyetemi Oktato Korhaz ( Site 0062)

    RECRUITING

    Győr, Győr-Moson-Sopron, 9024, Hungary

  • Rabin Medical Center ( Site 0074)

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rambam Health Care Campus ( Site 0076)

    RECRUITING

    Haifa, 3109601, Israel

  • Shaare Zedek Medical Center ( Site 0075)

    RECRUITING

    Jerusalem, 9103102, Israel

  • Shanghai Chest Hospital ( Site 0308)

    RECRUITING

    Shanghai, Shanghai Municipality, 200030, China

  • Shanghai Pulmonary Hospital ( Site 0300)

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

  • Sheba Medical Center ( Site 0070)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Sourasky Medical Center ( Site 0077)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie ( Site 0152)

    RECRUITING

    Koszalin, West Pomeranian Voivodeship, 75-581, Poland

  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 0204)

    RECRUITING

    Athens, Attica, 115 27, Greece

  • Texas Oncology - DFW ( Site 8003)

    RECRUITING

    Dallas, Texas, 75246-2046, United States

  • UniversitaetsklInikum Tuebingen ( Site 0192)

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • University of Kentucky Chandler Medical Center ( Site 0019)

    RECRUITING

    Lexington, Kentucky, 40536-0293, United States

  • Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 0153)

    RECRUITING

    Poznan, Greater Poland Voivodeship, 60-569, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.